Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Glaxosmithkline Plc

Glaxosmithkline Plc (GSK)

Market is closed
News
Relvar Ellipta: GlaxoSmithKline and Theravance’s Drug for Respiratory Diseases

Relvar Ellipta: GlaxoSmithKline and Theravance’s Drug for Respiratory Diseases

Relvar Ellipta: Over the past few days, research-based pharmaceutical GlaxoSmithKline plc (ADR) (NYSE:GSK) and biopharmaceutical company Theravance Inc (NASDAQ:THRX)’s Relvar Ellipta has been in the...

Keep Reading →

September 23rd, 2013 - News

Everything You Need to Know About the Upcoming Flu Season

Everything You Need to Know About the Upcoming Flu Season

To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.

Keep Reading →

September 23rd, 2013 - News

Investing in Counteracting Biological and Chemical Agents

Investing in Counteracting Biological and Chemical Agents

Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological agents.

Keep Reading →

September 23rd, 2013 - News

Sanofi SA (ADR) (SNY), Roche Holding Ltd. (ADR) (RHHBY), GlaxoSmithKline plc (ADR) (GSK): Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

Sanofi SA (ADR) (SNY), Roche Holding Ltd. (ADR) (RHHBY), GlaxoSmithKline plc (ADR) (GSK): Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

There is perhaps nothing scarier than a cancer diagnosis.

Keep Reading →

September 17th, 2013 - News

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.

Keep Reading →

September 17th, 2013 - News

Monster Beverage Corp (MNST), The Coca-Cola Company (KO), PepsiCo, Inc. (PEP): Will These Soft Drink Companies Go Flat?

Monster Beverage Corp (MNST), The Coca-Cola Company (KO), PepsiCo, Inc. (PEP): Will These Soft Drink Companies Go Flat?

There's no question that America is addicted to caffeine and sugar.

Keep Reading →

September 17th, 2013 - News

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?

GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease, commonly abbreviated...

Keep Reading →

September 16th, 2013 - News

Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will This Fishy Biotech Go Belly Up?

Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will This Fishy Biotech Go Belly Up?

There are plenty of biotech companies that put all of their eggs in one basket these days.

Keep Reading →

September 16th, 2013 - News

Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)'s Interest Sparks Biotech Stocks in a Huge Week for Investors

Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)'s Interest Sparks Biotech Stocks in a Huge Week for Investors

Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.

Keep Reading →

September 16th, 2013 - News

Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they're hot like summer, sometimes they're dormant and cold like winter. And sometimes they just fall.

Keep Reading →

September 16th, 2013 - News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)